Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

102 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Identification of drug candidates targeting monocyte reprogramming in people living with HIV.
Knoll R, Bonaguro L, Dos Santos JC, Warnat-Herresthal S, Jacobs-Cleophas MCP, Blümel E, Reusch N, Horne A, Herbert M, Nuesch-Germano M, Otten T, van der Heijden WA, van de Wijer L, Shalek AK, Händler K, Becker M, Beyer MD, Netea MG, Joosten LAB, van der Ven AJAM, Schultze JL, Aschenbrenner AC. Knoll R, et al. Among authors: otten t. Front Immunol. 2023 Nov 20;14:1275136. doi: 10.3389/fimmu.2023.1275136. eCollection 2023. Front Immunol. 2023. PMID: 38077315 Free PMC article.
Cardiometabolic Differences in People Living with HIV Receiving Integrase Strand Transfer Inhibitors Compared to Non-nucleoside Reverse Transcriptase Inhibitors: Implications for Current ART Strategies.
Vos WAJW, Vadaq N, Matzaraki V, Otten T, Groenendijk AL, Blaauw MJT, van Eekeren LE, Brinkman K, de Mast Q, Riksen NP, Stalenhoef AFH, van Lunzen J, van der Ven AJAM, Blok WL, Stalenhoef JE. Vos WAJW, et al. Among authors: otten t. Viruses. 2024 Apr 10;16(4):582. doi: 10.3390/v16040582. Viruses. 2024. PMID: 38675924 Free PMC article.
HIV immunological non-responders are characterized by extensive immunosenescence and impaired lymphocyte cytokine production capacity.
Vos WAJW, Navas A, Meeder EMG, Blaauw MJT, Groenendijk AL, van Eekeren LE, Otten T, Vadaq N, Matzaraki V, van Cranenbroek B, Brinkman K, van Lunzen J, Joosten LAB, Netea MG, Blok WL, van der Ven AJAM, Koenen HJPM, Stalenhoef JE. Vos WAJW, et al. Among authors: otten t. Front Immunol. 2024 May 8;15:1350065. doi: 10.3389/fimmu.2024.1350065. eCollection 2024. Front Immunol. 2024. PMID: 38779686 Free PMC article.
Bayesian Hierarchical Modelling for Histology-Independent Time-to-Event Outcomes in the NICE Single Technology Appraisal of Pembrolizumab for Solid Tumours with MSI-H/dMMR: External Assessment Group Perspective.
Sugden BM, Grimm SE, Wolff R, Armstrong N, Otten T, Abu-Zahra T, Perry M, Patel M, Chen J, Noake C, Joore M, Witlox WJA. Sugden BM, et al. Among authors: otten t. Pharmacoeconomics. 2024 Jun;42(6):615-618. doi: 10.1007/s40273-024-01381-z. Epub 2024 May 7. Pharmacoeconomics. 2024. PMID: 38713424 Free PMC article. No abstract available.
Oral Azacitidine for Maintenance Treatment of Acute Myeloid Leukaemia After Induction Therapy: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
Witlox W, Grimm S, Howick J, Armstrong N, Ahmadu C, McDermott K, Otten T, Noake C, Wolff R, Joore M. Witlox W, et al. Among authors: otten t. Pharmacoeconomics. 2023 Aug;41(8):857-867. doi: 10.1007/s40273-023-01272-9. Epub 2023 May 2. Pharmacoeconomics. 2023. PMID: 37129774 Free PMC article. Review.
Headroom Analysis for Early Economic Evaluation: A Systematic Review.
Boudewijns EA, Otten TM, Gobianidze M, Ramaekers BL, van Schayck OCP, Joore MA. Boudewijns EA, et al. Among authors: otten tm. Appl Health Econ Health Policy. 2023 Mar;21(2):195-204. doi: 10.1007/s40258-022-00774-5. Epub 2022 Dec 28. Appl Health Econ Health Policy. 2023. PMID: 36575333
102 results